Attrition in the pharmaceutical industry : reasons, implications, and pathways forward / / edited by Alexander Alex, C. John Harris, Dennis A. Smith |
Autore | Alex Alexander A. |
Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley, , 2016 |
Descrizione fisica | 1 online resource (373 p.) |
Disciplina | 615.1068/5 |
Soggetto topico |
Pharmaceutical industry - Management
Pharmaceutical industry - Capital productivity Industrial efficiency Drug development |
ISBN |
1-118-91434-1
1-118-81958-6 1-118-81944-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Attrition in drug discovery and development / Scott Boyer, Clive Brealey and Andrew M. Davis -- Compound attrition at the pre-clinical phase / Cornelis E.C.A. Hop -- Attrition in phase I / Dennis A. Smith and Thomas A. Baillie -- Compound attrition in phase II/III / Alexander Alex, C. John Harris, Wilma W. Keighley and Dennis A. Smith -- Post-marketing attrition / Dennis A. Smith -- Influence of the regulatory environment on attrition / Robert T. Clay -- Experimental screening strategies to reduce attrition risk / Marie-Claire Peakman, Matthew Troutman, Rose Gonzales and Anne Schmidt -- Medicinal chemistry strategies to prevent compound attrition / J. Richard Morphy -- Influence of phenotypic and target-based screening strategies on compound attrition and project choice / Andrew Bell, Wolfgang Fecke and Christine Williams -- In silico approaches to address compound attrition / Peter Gedeck, Christian Kramer, Richard Lewis -- Current and future strategies for improving drug discovery efficiency / Peter Mbugua Njogu and Kelly Chibale -- Impact of investment strategies, organizational structure and corporate environment on attrition, and future investment strategies to reduce attrition / Geoff Lawton. |
Record Nr. | UNINA-9910131531803321 |
Alex Alexander A. | ||
Hoboken, New Jersey : , : Wiley, , 2016 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Attrition in the pharmaceutical industry : reasons, implications, and pathways forward / / edited by Alexander Alex, C. John Harris, Dennis A. Smith |
Autore | Alex Alexander A. |
Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley, , 2016 |
Descrizione fisica | 1 online resource (373 p.) |
Disciplina | 615.1068/5 |
Soggetto topico |
Pharmaceutical industry - Management
Pharmaceutical industry - Capital productivity Industrial efficiency Drug development |
ISBN |
1-118-91434-1
1-118-81958-6 1-118-81944-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Attrition in drug discovery and development / Scott Boyer, Clive Brealey and Andrew M. Davis -- Compound attrition at the pre-clinical phase / Cornelis E.C.A. Hop -- Attrition in phase I / Dennis A. Smith and Thomas A. Baillie -- Compound attrition in phase II/III / Alexander Alex, C. John Harris, Wilma W. Keighley and Dennis A. Smith -- Post-marketing attrition / Dennis A. Smith -- Influence of the regulatory environment on attrition / Robert T. Clay -- Experimental screening strategies to reduce attrition risk / Marie-Claire Peakman, Matthew Troutman, Rose Gonzales and Anne Schmidt -- Medicinal chemistry strategies to prevent compound attrition / J. Richard Morphy -- Influence of phenotypic and target-based screening strategies on compound attrition and project choice / Andrew Bell, Wolfgang Fecke and Christine Williams -- In silico approaches to address compound attrition / Peter Gedeck, Christian Kramer, Richard Lewis -- Current and future strategies for improving drug discovery efficiency / Peter Mbugua Njogu and Kelly Chibale -- Impact of investment strategies, organizational structure and corporate environment on attrition, and future investment strategies to reduce attrition / Geoff Lawton. |
Record Nr. | UNINA-9910822342203321 |
Alex Alexander A. | ||
Hoboken, New Jersey : , : Wiley, , 2016 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|